Anti-LKM-1 Antibodies Test: Purpose & Results

When Jaundice and Fatigue Point to Autoimmune Hepatitis

In my clinical practice, I often see young patients, particularly women, who present with persistent fatigue, jaundice, and abnormal liver function tests. When common causes like viral hepatitis or alcohol are ruled out, the differential diagnosis shifts towards autoimmune liver diseases. Here, the Anti-LKM-1 antibody test becomes a pivotal tool in identifying a specific form of autoimmune hepatitis.

What Are Anti-LKM-1 Antibodies?

Anti-Liver/Kidney Microsomal Type 1 (Anti-LKM-1) antibodies are autoantibodies produced by the immune system that mistakenly target enzymes within liver and kidney cells. These antibodies are primarily associated with Autoimmune Hepatitis Type 2, a chronic condition where the body's immune system attacks the liver. The test is internationally standardized under the LOINC code 35278-1.

Why is the Anti-LKM-1 Test Ordered?

This test is typically requested when a patient shows signs of unexplained liver inflammation, such as elevated alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels. It is especially considered in children, adolescents, and young adults with suspected autoimmune hepatitis. My patients typically undergo this test after initial liver screenings suggest an autoimmune process rather than an infectious or metabolic cause.

Interpreting Your Anti-LKM-1 Test Results

Results are usually reported as positive or negative, sometimes with a titre indicating antibody concentration. A positive result strongly suggests Autoimmune Hepatitis Type 2, but it must be correlated with clinical symptoms, other liver tests, and sometimes a liver biopsy. A negative result makes this diagnosis less likely, though not impossible.

Is a Positive Anti-LKM-1 Test Dangerous?

A positive test itself is not dangerous, but it signals an underlying autoimmune attack on the liver. Untreated, Autoimmune Hepatitis Type 2 can lead to cirrhosis and liver failure. However, with early diagnosis and appropriate immunosuppressive treatment, the prognosis is generally good. In my experience, patients who adhere to therapy often achieve remission and maintain normal liver function.

Anti-LKM-1 in Paediatric Patients

Autoimmune Hepatitis Type 2 is more common in children and young adults. The presentation can be aggressive, with rapid onset of symptoms. Testing for Anti-LKM-1 is therefore a key part of the paediatric hepatology workup. Early detection is crucial to prevent long-term liver damage.

How is Autoimmune Hepatitis Type 2 Treated?

Treatment typically involves immunosuppressive medications like prednisone and azathioprine to calm the immune system and reduce liver inflammation. Response to therapy is monitored through repeat liver function tests and, in some cases, antibody titres. Most patients require long-term management to maintain remission.

Next Steps After an Abnormal Result

If your Anti-LKM-1 test is positive, the next step is usually a referral to a gastroenterologist or hepatologist. They will conduct a comprehensive assessment, which may include additional blood tests, imaging, and possibly a liver biopsy to confirm the diagnosis and stage the disease. Starting treatment early can effectively control the condition and preserve liver health.